Carcinogenesis Advance Access originally published online on December 19, 2005
Carcinogenesis 2006 27(6):1187-1193; doi:10.1093/carcin/bgi288
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DNA damage levels in prostate cancer cases and controls
1 Department of Cancer Biology, 2 Department of Urology and 3 Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA, 4 School of Public Health and 5 Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
* To whom correspondence should be addressed at: 533 Bolivar Street, CSRB-454, Stanley S. Scott Cancer Center and School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA. Tel: +1 504 568 2090; Fax: +1 504 568 6888; Email: jenhu{at}lsuhsc.edu
This study used the alkaline Comet assay to evaluate whether basal or H2O2-induced DNA damage is associated with prostate cancer (CaP) risk. Using lymphocyte samples from 158 CaP cases and 128 controls, collected in an ongoing casecontrol study, our results showed that basal DNA damage did not differ between cases and controls. However, the H2O2-induced DNA damage level was significantly higher in incident cases (mean ± SD; 6.61 ± 4.43, n = 102) than controls (5.30 ± 3.60, n = 128) or prevalent cases (4.47 ± 3.19; n = 56). Incident cases with a positive smoking history had significantly higher H2O2-induced DNA damage than never-smokers (7.57 ± 4.82 versus 4.52 ± 2.40; P < 0.001). Above-median H2O2-induced DNA damage was associated with a 1.61-fold increase in CaP risk [95% confidence interval (CI) = 0.922.81], after adjustment for age, race, benign prostatic hyperplasia (BPH), smoking history and family history (FH). Using the lowest quartile of H2O2-induced DNA damage as the referent group, the adjusted ORs for the 25th, 50th and 75th quartiles were 0.90 (95% CI = 0.392.05), 1.06 (95% CI = 0.482.35) and 2.05 (95% CI = 0.964.37), respectively (P = 0.046, test for linear trend). The association between CaP and DNA damage was modified by age, smoking history, family history and body mass index. Our results suggest that DNA damage may be associated with CaP risk. However, larger casecontrol and follow-up studies are warranted to further evaluate the potential application of the alkaline Comet assay in CaP risk assessment and prevention.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Zabaleta, H.-Y. Lin, R. A. Sierra, M.C. Hall, P. E. Clark, O. A. Sartor, J. J. Hu, and A. C. Ochoa Interactions of cytokine gene polymorphisms in prostate cancer risk Carcinogenesis, March 1, 2008; 29(3): 573 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Rybicki, C. Neslund-Dudas, C. H. Bock, A. Rundle, A. T. Savera, J. J. Yang, N. L. Nock, and D. Tang Polycyclic Aromatic Hydrocarbon-DNA Adducts in Prostate and Biochemical Recurrence after Prostatectomy Clin. Cancer Res., February 1, 2008; 14(3): 750 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Waters, S. Shen, H. Xu, S. S. Kengeri, D. M. Cooley, E. C. Chiang, Y. Chen, D. Schlittler, C. Oteham, G. F. Combs Jr., et al. Noninvasive Prediction of Prostatic DNA Damage by Oxidative Stress Challenge of Peripheral Blood Lymphocytes Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1906 - 1910. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kang, K.-M. Lee, S. K. Park, S. I. Berndt, U. Peters, D. Reding, N. Chatterjee, R. Welch, S. Chanock, W.-Y. Huang, et al. Functional Variant of Manganese Superoxide Dismutase (SOD2 V16A) Polymorphism Is Associated with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Study Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1581 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Choi, M. L. Neuhouser, M. Barnett, M. Hudson, A. R. Kristal, M. Thornquist, I. B. King, G. E. Goodman, and C. B. Ambrosone Polymorphisms in Oxidative Stress-Related Genes Are Not Associated with Prostate Cancer Risk in Heavy Smokers Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1115 - 1120. [Abstract] [Full Text] [PDF] |
||||


